WELLS FARGO & COMPANY/MN - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 152 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2013. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$0
-100.0%
2,324
+0.0%
0.00%
Q3 2018$1,000
-66.7%
2,323
-58.7%
0.00%
Q2 2018$3,000
-98.5%
5,623
-93.2%
0.00%
Q1 2018$194,000
+7.8%
83,114
+30.5%
0.00%
Q4 2017$180,000
-26.8%
63,682
-25.9%
0.00%
Q3 2017$246,000
+26.2%
85,985
+9.1%
0.00%
Q2 2017$195,000
-33.0%
78,802
-2.0%
0.00%
Q1 2017$291,000
-11.0%
80,402
-13.0%
0.00%
Q4 2016$327,000
+3.2%
92,399
+17.9%
0.00%
Q3 2016$317,000
+21.0%
78,383
+31.2%
0.00%
Q2 2016$262,000
+13.4%
59,722
-2.3%
0.00%
Q1 2016$231,000
-97.4%
61,139
-89.1%
0.00%
-100.0%
Q4 2015$8,823,000
+35.5%
562,734
-8.9%
0.00%0.0%
Q3 2015$6,513,000
-43.4%
617,867
+35.4%
0.00%
-25.0%
Q2 2015$11,508,000
-36.0%
456,276
-29.9%
0.00%
+33.3%
Q1 2015$17,972,000
+167.2%
651,276
+76.7%
0.00%0.0%
Q4 2014$6,726,000
+1021.0%
368,548
+696.2%
0.00%
Q3 2014$600,000
-34.9%
46,290
-18.0%
0.00%
Q2 2014$922,000
-43.4%
56,475
-38.7%
0.00%
-100.0%
Q1 2014$1,630,000
+21.3%
92,155
+66.0%
0.00%0.0%
Q4 2013$1,344,000
+58.1%
55,513
+131.2%
0.00%
Q3 2013$850,000
+1417.9%
24,008
+568.6%
0.00%
Q2 2013$56,0003,5910.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2013
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders